-
1
-
-
0022875839
-
In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis
-
Das SN, Khanna NN and Khanna S: In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis. Cancer Invest 4(3): 207-216, 1986.
-
(1986)
Cancer Invest
, vol.4
, Issue.3
, pp. 207-216
-
-
Das, S.N.1
Khanna, N.N.2
Khanna, S.3
-
2
-
-
0023710486
-
Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes and tumor of head and neck cancer patients
-
Mickel R, Kessler D, Taylor J and Lichenstein A: Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes and tumor of head and neck cancer patients. Cancer Res 48: 5017-5022, 1988.
-
(1988)
Cancer Res
, vol.48
, pp. 5017-5022
-
-
Mickel, R.1
Kessler, D.2
Taylor, J.3
Lichenstein, A.4
-
3
-
-
0022476775
-
Natural killer cell activity and head and neck cancer: A clinical assessment
-
Schantz S, Shillitoe E, Brown B and Campbell B: Natural killer cell activity and head and neck cancer: a clinical assessment. J Nat Cancer Inst 77: 869-875, 1986.
-
(1986)
J Nat Cancer Inst
, vol.77
, pp. 869-875
-
-
Schantz, S.1
Shillitoe, E.2
Brown, B.3
Campbell, B.4
-
4
-
-
0023572178
-
Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis
-
Wolf GT, Schmaltz S, Hudson J, Robson H, Stackhouse T, Peterson KA, Poore JA and McClatchey KD: Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis. Arch Otolaryngol Head Neck Surg 113(11): 1200-1206, 1987.
-
(1987)
Arch Otolaryngol Head Neck Surg
, vol.113
, Issue.11
, pp. 1200-1206
-
-
Wolf, G.T.1
Schmaltz, S.2
Hudson, J.3
Robson, H.4
Stackhouse, T.5
Peterson, K.A.6
Poore, J.A.7
McClatchey, K.D.8
-
7
-
-
0030300154
-
The complexities of T-cell costimulation: CD28 and beyond
-
Sperling AI and Bluestone JA: The complexities of T-cell costimulation: CD28 and beyond. Immunol Rev 153: 155-182, 1996.
-
(1996)
Immunol Rev
, vol.153
, pp. 155-182
-
-
Sperling, A.I.1
Bluestone, J.A.2
-
8
-
-
0027982995
-
Tumor immunogenicity determines the effect of B7 co-stimulation on T-cell mediated tumor immunity
-
Chen L, McGowan P, Ashe S, Johnston J, Li Y, Hellstrom I and Hellstrom KE: Tumor immunogenicity determines the effect of B7 co-stimulation on T-cell mediated tumor immunity. J Exp Med 179: 523-532, 1994.
-
(1994)
J Exp Med
, vol.179
, pp. 523-532
-
-
Chen, L.1
McGowan, P.2
Ashe, S.3
Johnston, J.4
Li, Y.5
Hellstrom, I.6
Hellstrom, K.E.7
-
9
-
-
0030474719
-
Tumor cells transfected with B7-1 and interleukin-12 cDNA induce protective immunity
-
Chen P, Geer DC, Podack ER and Ksander B: Tumor cells transfected with B7-1 and interleukin-12 cDNA induce protective immunity. Ann NY Acad Sci 795: 325-327, 1996.
-
(1996)
Ann NY Acad Sci
, vol.795
, pp. 325-327
-
-
Chen, P.1
Geer, D.C.2
Podack, E.R.3
Ksander, B.4
-
10
-
-
0028793303
-
B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma
-
Yeh K, Pulaski BA, Woods ML, McAdam AJ, Gaspari AA, Frelinger JG and Lord EM: B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell Immunol 165: 217-224, 1995.
-
(1995)
Cell Immunol
, vol.165
, pp. 217-224
-
-
Yeh, K.1
Pulaski, B.A.2
Woods, M.L.3
McAdam, A.J.4
Gaspari, A.A.5
Frelinger, J.G.6
Lord, E.M.7
-
11
-
-
0036223749
-
Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma
-
Antonia SJ, Seigne J, Diaz J, Muro-Cacho C, Extermann M, Farmelo MJ, Friberg M, Alsarraj M, Mahany JJ, Pow-Sang J, Cantor A and Janssen W: Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma. J Urol 167(5): 1995-2000, 2002.
-
(2002)
J Urol
, vol.167
, Issue.5
, pp. 1995-2000
-
-
Antonia, S.J.1
Seigne, J.2
Diaz, J.3
Muro-Cacho, C.4
Extermann, M.5
Farmelo, M.J.6
Friberg, M.7
Alsarraj, M.8
Mahany, J.J.9
Pow-Sang, J.10
Cantor, A.11
Janssen, W.12
-
12
-
-
0037413950
-
Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules
-
Briones J, Timmerman JM, Panicalli DL and Levy R: Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules. J National Cancer Institute 95(7): 548-555, 2003.
-
(2003)
J National Cancer Institute
, vol.95
, Issue.7
, pp. 548-555
-
-
Briones, J.1
Timmerman, J.M.2
Panicalli, D.L.3
Levy, R.4
-
13
-
-
0033766694
-
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
-
Horig H, Lee DS, Conkright W, Divito J, Hasson H, LaMare M, Rivera A, Park D, Tine J, Guito K, Tsang KW, Schlom J and Kaufman HL: Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunol Immunother 49(9): 504-514, 2000.
-
(2000)
Cancer Immunol Immunother
, vol.49
, Issue.9
, pp. 504-514
-
-
Horig, H.1
Lee, D.S.2
Conkright, W.3
Divito, J.4
Hasson, H.5
LaMare, M.6
Rivera, A.7
Park, D.8
Tine, J.9
Guito, K.10
Tsang, K.W.11
Schlom, J.12
Kaufman, H.L.13
-
14
-
-
0033046904
-
Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma
-
Thomas GR, Chen Z, Oechsli M, Hendler JH and Van Waes C: Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma. Int J Cancer 82: 377-384, 1999.
-
(1999)
Int J Cancer
, vol.82
, pp. 377-384
-
-
Thomas, G.R.1
Chen, Z.2
Oechsli, M.3
Hendler, J.H.4
Van Waes, C.5
-
15
-
-
2642679457
-
Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T-cell response
-
Wendtner CM, Nolte A, Mangold E, Buhmann R, Maass G, Chiorini JA, Winnacker EL, Emmerich B, Kotin RM and Hallek M: Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T-cell response. Gene Ther 4(7): 726-735, 1997.
-
(1997)
Gene Ther
, vol.4
, Issue.7
, pp. 726-735
-
-
Wendtner, C.M.1
Nolte, A.2
Mangold, E.3
Buhmann, R.4
Maass, G.5
Chiorini, J.A.6
Winnacker, E.L.7
Emmerich, B.8
Kotin, R.M.9
Hallek, M.10
-
16
-
-
0037324057
-
Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission
-
Whiteway A, Corbett T, Anderson R, Macdonald I and Prentice HG: Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission. Br J Haematol 120(3): 442-451, 2003.
-
(2003)
Br J Haematol
, vol.120
, Issue.3
, pp. 442-451
-
-
Whiteway, A.1
Corbett, T.2
Anderson, R.3
Macdonald, I.4
Prentice, H.G.5
-
17
-
-
0742269447
-
Cytokines IL-1 alpha, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: Restoration by interferon gamma
-
Thomas GR, Chen Z, Leukinova E, Van Waes C and Wen J: Cytokines IL-1 alpha, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon gamma. Cancer Immunol Immunother 53(1): 33-40, 2004.
-
(2004)
Cancer Immunol Immunother
, vol.53
, Issue.1
, pp. 33-40
-
-
Thomas, G.R.1
Chen, Z.2
Leukinova, E.3
Van Waes, C.4
Wen, J.5
-
18
-
-
0027439005
-
Costimulation of T-cells for tumor immunity
-
Chen L, Linsley PS and Hellstrom KE: Costimulation of T-cells for tumor immunity. Immunol Today 14(10): 483-486, 1993.
-
(1993)
Immunol Today
, vol.14
, Issue.10
, pp. 483-486
-
-
Chen, L.1
Linsley, P.S.2
Hellstrom, K.E.3
-
19
-
-
0242329384
-
Modulation of costimulation to enhance tumor immunity
-
Vesosky B and Hurwitz AA: Modulation of costimulation to enhance tumor immunity. Cancer Immunol Immunother 52(11): 663-669, 2003.
-
(2003)
Cancer Immunol Immunother
, vol.52
, Issue.11
, pp. 663-669
-
-
Vesosky, B.1
Hurwitz, A.A.2
-
20
-
-
20144389834
-
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs
-
Frankenberger B, Pohla H, Noessner E, Willimsky G, Papier B, Pezzutto A, Kopp J, Oberneder R, Blankenstein T and Schendel DJ: Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs. Clin Cancer Res 11(5): 1733-1742, 2005.
-
(2005)
Clin Cancer Res
, vol.11
, Issue.5
, pp. 1733-1742
-
-
Frankenberger, B.1
Pohla, H.2
Noessner, E.3
Willimsky, G.4
Papier, B.5
Pezzutto, A.6
Kopp, J.7
Oberneder, R.8
Blankenstein, T.9
Schendel, D.J.10
-
21
-
-
0035963379
-
-
Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, Hemmi S, Hengartner H and Zinkernagel RM: Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411(6841): 1058-1064, 2001. Erratum in: Nature 413(6852): 183, 2001.
-
Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, Hemmi S, Hengartner H and Zinkernagel RM: Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411(6841): 1058-1064, 2001. Erratum in: Nature 413(6852): 183, 2001.
-
-
-
-
22
-
-
0038826485
-
Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: Clinical and immunological results
-
Dois A, Smith JW 2nd, Meijer SL, Fox BA, Hu HM, Walker E, Rosenheim S, Moudgil T, Doran T, Wood W, Seligman M, Alvord WG, Schoof D and Urba WJ: Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results. Hum Gene Ther 14(11): 1117-1123, 2003.
-
(2003)
Hum Gene Ther
, vol.14
, Issue.11
, pp. 1117-1123
-
-
Dois, A.1
Smith II, J.W.2
Meijer, S.L.3
Fox, B.A.4
Hu, H.M.5
Walker, E.6
Rosenheim, S.7
Moudgil, T.8
Doran, T.9
Wood, W.10
Seligman, M.11
Alvord, W.G.12
Schoof, D.13
Urba, W.J.14
-
23
-
-
22144457398
-
Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma
-
Kaufman HL, Deraffele G, Mitcham J, Moroziewicz D, Cohen SM, Hurst-Wicker KS, Cheung K, Lee DS, Divito J, Voulo M, Donovan J, Dolan K, Manson K, Panicali D, Wang E, Horig H and Marincola FM: Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma. J Clin Invest 115(7): 1903-1912, 2005.
-
(2005)
J Clin Invest
, vol.115
, Issue.7
, pp. 1903-1912
-
-
Kaufman, H.L.1
Deraffele, G.2
Mitcham, J.3
Moroziewicz, D.4
Cohen, S.M.5
Hurst-Wicker, K.S.6
Cheung, K.7
Lee, D.S.8
Divito, J.9
Voulo, M.10
Donovan, J.11
Dolan, K.12
Manson, K.13
Panicali, D.14
Wang, E.15
Horig, H.16
Marincola, F.M.17
-
24
-
-
4344559720
-
Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer
-
Raez LE, Cassileth PA, Schlesselman JJ, Sridhar K, Padmanabhan S, Fisher EZ, Baldie PA and Podack ER: Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer. J Clin Oncol 22(14): 2800-2807, 2004.
-
(2004)
J Clin Oncol
, vol.22
, Issue.14
, pp. 2800-2807
-
-
Raez, L.E.1
Cassileth, P.A.2
Schlesselman, J.J.3
Sridhar, K.4
Padmanabhan, S.5
Fisher, E.Z.6
Baldie, P.A.7
Podack, E.R.8
-
25
-
-
13844294372
-
PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T-cells
-
Iwai Y, Terawaki S and Honjo T: PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T-cells. Int Immunol 17(2): 133-114, 2005.
-
(2005)
Int Immunol
, vol.17
, Issue.2
, pp. 133-114
-
-
Iwai, Y.1
Terawaki, S.2
Honjo, T.3
-
26
-
-
20244384862
-
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
-
Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, Mizuno T, Yoriki R, Kashizuka H, Yane K, Tsushima F, Otsuki N, Yagita H, Azuma M and Nakajima Y: Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res 11(8): 2947-2953, 2005.
-
(2005)
Clin Cancer Res
, vol.11
, Issue.8
, pp. 2947-2953
-
-
Ohigashi, Y.1
Sho, M.2
Yamada, Y.3
Tsurui, Y.4
Hamada, K.5
Ikeda, N.6
Mizuno, T.7
Yoriki, R.8
Kashizuka, H.9
Yane, K.10
Tsushima, F.11
Otsuki, N.12
Yagita, H.13
Azuma, M.14
Nakajima, Y.15
-
27
-
-
0037867039
-
B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism
-
Liu X, Gao JX, Wen J, Yin L, Li O, Zuo T, Gajewski TF, Fu YX, Zheng P and Liu Y: B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med 197(12): 1721-1730, 2003.
-
(2003)
J Exp Med
, vol.197
, Issue.12
, pp. 1721-1730
-
-
Liu, X.1
Gao, J.X.2
Wen, J.3
Yin, L.4
Li, O.5
Zuo, T.6
Gajewski, T.F.7
Fu, Y.X.8
Zheng, P.9
Liu, Y.10
-
28
-
-
6344241440
-
B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T-cells
-
Luo L, Chapoval AI, Flies DB, Zhu G, Hirano F, Wang S, Lau JS, Dong H, Tamada K, Flies AS, Liu Y and Chen L: B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T-cells. J Immunol 173(9): 5445-5450, 2004.
-
(2004)
J Immunol
, vol.173
, Issue.9
, pp. 5445-5450
-
-
Luo, L.1
Chapoval, A.I.2
Flies, D.B.3
Zhu, G.4
Hirano, F.5
Wang, S.6
Lau, J.S.7
Dong, H.8
Tamada, K.9
Flies, A.S.10
Liu, Y.11
Chen, L.12
-
29
-
-
0141851079
-
Mouse B7-H3 induces antitumor immunity
-
Sun X, Vale M, Leung E, Kanwar JR, Gupta R and Krissansen GW: Mouse B7-H3 induces antitumor immunity. Gene Ther 10(20): 1728-1734, 2003.
-
(2003)
Gene Ther
, vol.10
, Issue.20
, pp. 1728-1734
-
-
Sun, X.1
Vale, M.2
Leung, E.3
Kanwar, J.R.4
Gupta, R.5
Krissansen, G.W.6
-
30
-
-
21344456553
-
Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: Novel cancer escaping mechanisms
-
Ichikawa M and Chen L: Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms. Front Biosci 10: 2856-2860, 2005.
-
(2005)
Front Biosci
, vol.10
, pp. 2856-2860
-
-
Ichikawa, M.1
Chen, L.2
-
31
-
-
18844373949
-
The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation
-
Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, Macina R, Liu W, Pilkington G and Papkoff J: The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 306(1): 128-141, 2005.
-
(2005)
Exp Cell Res
, vol.306
, Issue.1
, pp. 128-141
-
-
Salceda, S.1
Tang, T.2
Kmet, M.3
Munteanu, A.4
Ghosh, M.5
Macina, R.6
Liu, W.7
Pilkington, G.8
Papkoff, J.9
|